you are here:

Natco Pharma Ltd.

BSE: 524816 | NSE: NATCOPHARM |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE987B01026 | SECTOR: Pharmaceuticals

BSE Live

Nov 26, 16:00
899.30 2.70 (0.30%)
Volume
AVERAGE VOLUME
5-Day
9,346
10-Day
8,134
30-Day
8,304
9,695
  • Prev. Close

    896.60

  • Open Price

    914.00

878.80

Today’s L/H

914.00
450.00

52 Wk L/H

995.05
717.30

L/U Price Band

1075.90
  • Bid Price (Qty.)

    904.00 (25)

  • Offer Price (Qty.)

    0.00 (0)

  •  VWAP

    887.79
     Beta
    0.46
  • Market Depth (26 Nov 2020)

    BUYSELL
    QTY PRICE PRICE QTY
    25 904.00 905.00 150
    177 902.30 908.25 45
    421 902.10 908.45 177
    20 902.00 908.65 199
    45 901.80 908.75 222
    3691 Total Total 957
     Market Depth
    BUY 3691.00
    SELL 957.00
    79%
    21%

NSE Live

Nov 26, 15:56
899.80 2.75 (0.31%)
Volume
AVERAGE VOLUME
5-Day
371,203
10-Day
360,086
30-Day
326,590
405,164
  • Prev. Close

    897.05

  • Open Price

    890.60

878.00

Today’s L/H

912.00
402.55

52 Wk L/H

996.00
717.65

L/U Price Band

1076.45
  • Bid Price (Qty.)

    899.80 (1583)

  • Offer Price (Qty.)

    0.00 (0)

  •  VWAP

    888.44
     Beta
    0.51
  • DELIVERY AVERAGES
    3-Day
    56.44%
    5-Day
    45.97%
    8-Day
    48.37%
    Deliverables
  • SMA
    30
    909.31
    50
    908.96
    150
    764.07
    200
    720.40
    SMA
    909.31
Powered by Trendlyne

Charts

  • Open : -
  • High : -
  • Low -
  • Close: -
  • Volume -

TECHNICAL ANALYSIS

TECHNICAL RATING
bearish
Moving Averages Bearish
Technical Indicators Bearish
Moving Averages Crossovers Neutral
Pivot levels
Type R1 R2 R3 PP S1 S2 S3
Classic 915.20 930.60 949.20 896.60 881.20 862.60 847.20
Fibonacci 909.59 917.61 930.60 896.60 883.61 875.59 862.60
Camarilla 902.92 906.03 909.15 896.60 896.68 893.57 890.45

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

SIMPLE MOVING AVERAGES
Days NSE
5 906.75
10 905.95
20 905.87
50 908.96
100 837.76
200 720.40
Pivot levels

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

Pivot levels

Type R1 R2 R3 PP S1 S2 S3
Classic 928.17 944.03 968.17 904.03 888.17 864.03 848.17
Fibonacci 919.31 928.75 944.03 904.03 888.75 879.31 864.03
Camarilla 915.97 919.63 923.30 904.03 908.63 904.97 901.30

Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

SIMPLE MOVING AVERAGES
Pivot levels

Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

Pivot levels
Type R1 R2 R3 PP S1 S2 S3
Classic 960.67 1020.93 1068.37 913.23 852.97 805.53 745.27
Fibonacci 954.37 979.79 1020.93 913.23 872.09 846.67 805.53
Camarilla 910.27 920.14 930.02 913.23 890.53 880.66 870.78

Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

SIMPLE MOVING AVERAGES
Pivot levels

Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

Valuation

    • Market Cap (Rs Cr.)
      16,384.02
    • P/E
      40.75
    • Book Value (Rs)
      212.39
    • Dividend (%)
      337.50
    • Market Lot
      1
    • Industry P/E
      37.41
    • EPS (TTM)
      22.08
    • P/C
      32.77
    • Price/Book
      4.23
    • Dividend Yield.(%)
      0.75
    • Face Value (RS)
      2.00
    • Deliverables (%)
      DELIVERY AVERAGES (%)
      3-Day
      56.44
      5-Day
      45.97
      8-Day
      48.37
      56.81

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

    • Market Cap (Rs Cr.)
      16,384.02
    • P/E
      31.30
    • Book Value (Rs)
      207.74
    • Dividend (%)
      337.50
    • Market Lot
      1
    • Industry P/E
      37.41
    • EPS (TTM)
      28.75
    • P/C
      26.27
    • Price/Book
      4.33
    • Dividend Yield.(%)
      0.75
    • Face Value (RS)
      2.00
    • Deliverables (%)
      DELIVERY AVERAGES (%)
      3-Day
      56.44
      5-Day
      45.97
      8-Day
      48.37
      56.81

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

Forum

Community Sentiments

No Data For Community Sentiments.

What's your call on today?

Read 0 investor views

BUY SELL HOLD

Action in Natco Pharma Ltd.

Pre-Opening Session Prices9:00 am - 9:15 am

BSE

Nov 27, 09:15
914.00 17.40 (1.94%)
High 935.00
Low 914.00
Prev. Close 896.60

NSE

Nov 27, 09:15
890.60 -6.45 (-0.72%)
High 896.40
Low 890.60
Prev. Close 897.05

Financials

(Rs. Cr)
Quarterly SEP 2020 JUN 2020 MAR 2020 DEC 2019 SEP 2019
Sales
802 563 454 482 485
Other Income
25 18 22 30 33
Total Income
827 582 477 513 518
Total Expenditure
554 420 357 378 373
EBIT
273 161 120 134 145
Interest
2 3 3 5 6
Tax
66 36 23 24 21
Net Profit
203 122 93 104 117

Historical Prices

On
Current Price %Gain / Loss
Open Price 571.75 914.00
59.86
High Price 573.15 914.00
59.47
Low Price 567.00 878.80
54.99
Close Price 571.55 896.60
56.87
Volume 2,807 9,695
245.39
On
Current Price %Gain / Loss
Open Price 572.10 890.60
55.67
High Price 575.00 912.00
58.61
Low Price 565.55 878.00
55.25
Close Price 571.85 897.05
56.87
Volume 190,811 405,164
112.34
Click Here to view the Open, High, Low, Close, Volume and Historic data for
Index Price Change %Chg
NIFTY 50 12987.00 128.60 1.00
SENSEX 44259.74 431.64 0.98
NIFTY BANK 29549.75 353.35 1.21
NIFTY IT 21859.90 154.00 0.71
S&P BSE Smallcap 16480.06 116.77 0.71
Index Price Change %Chg
Nikkei 225 (Nov 27) 26,517.95 -19.36 -0.07
KOSPI (Nov 27) 2,623.45 -2.46 -0.09
Straits Times (Nov 27) 2,848.52 -8.96 -0.31
Taiwan Weighted (Nov 27) 13,843.60 -2.06 -0.01
SGX Nifty (Nov 27) 13,055.50 10.00 0.08

CORPORATE ACTION

Date Agenda
Nov 12, 2020 Quarterly Results & Interim Dividend
Aug 12, 2020 Quarterly Results & Interim Dividend
Jun 17, 2020 Audited Results & 4th Interim Divided
Feb 12, 2020 Quarterly Results & 3rd Interim Dividend
Type Dividend% Ex-Dividend date
Interim 150.00 Nov 24, 2020
Interim 62.50 Aug 21, 2020
Interim 50.00 Jun 26, 2020
Interim 175.00 Feb 24, 2020
Interim 50.00 Nov 21, 2019
Ratio Announcement Date Ex-Bonus
No Bonus Information is available for Natco Pharma
Old FV New FV Ex-Split
10 2 Nov 26, 2015
Ratio Premium Ex-Bonus
No Rights Information is available for Natco Pharma
Date Agenda
Oct 15, 2020 -
Sep 05, 2019 -
Sep 15, 2018 -
Sep 28, 2017 (Revised)
Sep 30, 2016 -

Dividend Summary

For the year ending March 2020 Natco Pharma has declared an equity dividend of 337.50% amounting to Rs 6.75 per share. At the current share price of Rs 899.80 this results in a dividend yield of 0.75%.

The company has a good dividend track report and has consistently declared dividends for the last 5 years.

SHARE HOLDING PATTERN & MUTUAL FUND HOLDING

Share Holding Pattern in (%)

Standalone June 2020 March 2020 December 2019 June 2019
Promoters 48.93 48.93 48.98 49.01
Pledged 0 0 0 0
FII/FPI 20.4 21.67 21.98 20.1
Total DII 15.69 14.44 13.76 12.83
Fin.Insts 0.22 1.06 1.08 1.04
Insurance Co 0 0 0 0
MF 8.67 8.5 7.9 6.84
Others DIIs 6.8 4.88 4.78 4.95
Others 14.98 14.96 15.28 18.05
Total 100 100 100 99.99

PEERS COMPARISON

Company Name Last Price % Change 52 Wk High 52 Wk Low Market Cap Sales Qtr Net Profit Qtr
Natco Pharma 899.30 0.30 995.05 450.00 16384.02 1,790.20 474.50
Sun Pharma 511.60 1.04 564.90 315.20 122749.98 12,531.93 3,211.14
Divis Labs 3545.35 2.09 3636.00 1632.70 94117.9 5,310.57 1,372.71
Dr Reddys Labs 4898.80 1.92 5514.65 2497.60 81459.69 11,850.40 2,937.70
Cipla 738.05 0.92 829.00 356.75 59519.75 12,659.15 2,318.17

COMPANY OVERVIEW

Natco Pharma Limited was incorporated in Hyderabad in the year 1981 with an initial investment of INR 3.3 million.It is an India-based company engaged in manufacturing active pharmaceutical ingredients.The Companys segments include bulk chemicals, finished dosage formulations, retail pharmacy and job work charges. The Companys products in the oncology segment include Desifer, Veenat, Bendit, Bortenat, Lenalid and Clokeran. The Companys product offerings in the pharma segment include T-Score, PT-MaX, Glatimer, Tarana and Tigi. The Company operates in India, United States of America, Europe and the rest of the world.

COMPANY INFORMATION

  • Registered Office

  • Registrars

    • Name

      Venture Capital & Corporate Investments Pvt. Ltd.

    • Address

      Bharat Nagar

    • City

      Hyderabad 500018

    • State

      Telangana

    • Tel. No.

      040-23818475, 23818476, 23868023

    • Fax No.

      040-23868024

    • Email

      info@vccilindia.com

    • Internet

      http://www.vccilindia.com

  • Management

    • Name

      Designation

    • V C Nannapaneni

      Chairman & Managing Director

    • Rajeev Nannapaneni

      Vice Chairman & CEO

    • T V Rao

      Independent Director

    • G S Murthy

      Independent Director

    • D G Prasad

      Independent Director

  • Listing

    Whether The Company Forms A Part Of The Following Indices -
    • Sensex

      No

    • Nifty

      No

    • Bse-100

      No

    • Bse-200

      Yes

    • S&P CNX 500

      Yes

    • CNX Midcap

      No

About Natco Pharma Ltd.

Natco Pharma is in the Pharmaceuticals sector.

It is listed on the BSE with a BSE Code of 524816 and the NSE with an NSE Code of NATCOPHARM.

Related Searches